Clinical Trial Update: Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating cinacalcet in peritoneal dialysis patients with secondary hyperparathyroidism to lower iPTH levels has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Secondary Hyperparathyroidism | Phase 4 | Status: COMPLETED